Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The activation of the highly conserved unfolded protein response (UPR) is prominent in the pathogenesis of the most prevalent neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), which are classically characterized by an accumulation of aggregated or misfolded proteins. This activation is orchestrated by three endoplasmic reticulum (ER) stress sensors: PERK, ATF6 and IRE1. These sensors transduce signals that induce the expression of the UPR gene programme. Here, we first identified an early activator of the UPR and investigated the role of a chronically activated UPR in the pathogenesis of X-linked adrenoleukodystrophy (X-ALD), a neurometabolic disorder that is caused by ABCD1 malfunction; ABCD1 transports very long-chain fatty acids (VLCFA) into peroxisomes. The disease manifests as inflammatory demyelination in the brain or and/or degeneration of corticospinal tracts, thereby resulting in spastic paraplegia, with the accumulation of intracellular VLCFA instead of protein aggregates. Using X-ALD mouse model (Abcd1 − and Abcd1 − /Abcd2 −/− mice) and X-ALD patient’s fibroblasts and brain samples, we discovered an early engagement of the UPR. The response was characterized by the activation of the PERK and ATF6 pathways, but not the IRE1 pathway, showing a difference from the models of AD, PD or ALS. Inhibition of PERK leads to the disruption of homeostasis and increased apoptosis during ER stress induced in X-ALD fibroblasts. Redox imbalance appears to be the mechanism that initiates ER stress in X-ALD. Most importantly, we demonstrated that the bile acid tauroursodeoxycholate (TUDCA) abolishes UPR activation, which results in improvement of axonal degeneration and its associated locomotor impairment in Abcd1 − /Abcd2 −/− mice. Altogether, our preclinical data provide evidence for establishing the UPR as a key drug target in the pathogenesis cascade. Our study also highlights the potential role of TUDCA as a treatment for X-ALD and other axonopathies in which similar molecular mediators are implicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ER Stress Induces Cleavage of Membrane-Bound ATF6 by the Same Proteases that Process SREBPs
Ye, J., Rawson, R. B., Komuro, R., Chen, X., Davé, U. P., Prywes, R., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00133-7 · Cited by 1,871 · cited 1×
“ATF6 is a transcription factor that translocates to the Golgi compartment upon ER stress, where it is cleaved [105].”
BackgroundHematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 2×
“Under normal conditions, these proteins would be degraded by the proteasome or autophagy routes, which may not occur in X-ALD as both systems are malfunctioning, as we have previously reported [8, 9].”
BackgroundDisturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684 · cited 6×
“Thus, in mammalian cells all three pathways, which are the so-called ER stress sensors, are involved in the UPR and have partially overlapping roles as described below [36, 82, 100].”
BackgroundInfluentialMoser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
The Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600
Wanders, R. J. A., Waterham, H. R., & Ferdinandusse, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00083 · Cited by 366 · cited 4×
“Peroxisomes are oxidative organelles present in all tissues and organisms [83, 84, 102, 103] and are involved in several anabolic and catabolic reactions, including the following: the degradation of long- and very long-chain fatty acids (LCFA, VLCFA (C ≥ 22:0), respectively) by α- or β-oxidation and hydrogen peroxide…”
BackgroundInfluentialAubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366 · cited 1×
“Therapeutic options are scarce, and when diagnosed early, the cerebral forms of the disease are only adequately treatable with a bone marrow transplant [1] or, recently,”
BackgroundA mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293 · cited 2×
“Generation and genotyping for Abcd1− and Abcd1−/Abcd2−/− mice have been previously described [59, 75, 76].”
MethodThe human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters
van Roermund, C. W. T., Visser, W. F., IJlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H. R., & Wanders, R. J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110866 · Cited by 233 · cited 2×
“In addition, VLCFA are elongated from C16:0 in the ER [50, 68], and subsequently imported by ABCD1 and ABCD2 transporters into peroxisomes for degradation via β-oxidation [30, 93].”
BackgroundPujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214 · cited 5×
“These mice exhibit metabolic signs of pathology, including oxidative stress [29] and altered energy homeostasis [34]; however, the first clinical signs of AMN (axonopathy and locomotor impairment) appear at 20 months [76].”
BackgroundMethodInfluentialSelf-citationEarly oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn085 · Cited by 214 · cited 3×
“Using this mouse model and patient samples, studies by our laboratory and others have revealed that VLCFA-induced oxidative stress is an early, key pathogenic factor in X-ALD [29, 31, 35, 57, 73, 74, 85, 94], although the exact mechanisms by which oxidative stress causes neurodegeneration in X-ALD are not entirely cle…”
BackgroundSelf-citationPujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201 · cited 4×
“Generation and genotyping for Abcd1− and Abcd1−/Abcd2−/− mice have been previously described [59, 75, 76].”
BackgroundMethodInfluentialSelf-citationHo, J. K., Moser, H., Kishimoto, Y., & Hamilton, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118182 · Cited by 199 · cited 1×
“We thus posit that VLCFA excess may modify the fluidity of the ER lipid bilayer, as shown in model membranes [38, 104].”
BackgroundPeroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194 · cited 1×
“We thus hypothesize that late UPR activation, such as that for AD or PD when compared with that for peroxisomal disorders may be related to the phenomenon of deteriorating peroxisomal fitness over time, as observed during ageing and neurodegenerative disorders [5, 21, 32, 63, 89].”
BackgroundNunes, A. F., Amaral, J. D., Lo, A. C., Fonseca, M. B., Viana, R. J. S., Callaerts-Vegh, Z., D’Hooge, R., & Rodrigues, C. M. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8256-y · Cited by 192 · cited 1×
“The dose and duration of TUDCA, whose pharmacokinetics have been extensively studied in rodents [14], was based on pilot studies using APP/PS1 mice and other models [11, 67].”
MethodHein, S., Schonfeld, P., Kahlert, S., & Reiser, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn066 · Cited by 180 · cited 1×
“Using this mouse model and patient samples, studies by our laboratory and others have revealed that VLCFA-induced oxidative stress is an early, key pathogenic factor in X-ALD [29, 31, 35, 57, 73, 74, 85, 94], although the exact mechanisms by which oxidative stress causes neurodegeneration in X-ALD are not entirely cle…”
BackgroundAbsence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities†
Dirkx, R., Vanhorebeek, I., Martens, K., Schad, A., Grabenbauer, M., Fahimi, D., Declercq, P., Van Veldhoven, P. P., & Baes, M. (2005) · Hepatology · doi:10.1002/hep.20628 · Cited by 174 · cited 1×
“Morphological abnormalities of the ER compartment have been described in peroxisomal mutants, including Pex5−/− [18] and Abcd2−/− mice [27].”
BackgroundThe role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Ofman, R., Dijkstra, I. M. E., van Roermund, C. W. T., Burger, N., Turkenburg, M., van Cruchten, A., van Engen, C. E., Wanders, R. J. A., & Kemp, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000061 · Cited by 170 · cited 2×
“In addition, VLCFA are elongated from C16:0 in the ER [50, 68], and subsequently imported by ABCD1 and ABCD2 transporters into peroxisomes for degradation via β-oxidation [30, 93].”
BackgroundWhitcomb, R. W., Linehan, W. M., & Knazek, R. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113292 · Cited by 168 · cited 1×
“We thus posit that VLCFA excess may modify the fluidity of the ER lipid bilayer, as shown in model membranes [38, 104].”
BackgroundCastro-Caldas, M., Carvalho, A. N., Rodrigues, E., Henderson, C. J., Wolf, C. R., Rodrigues, C. M. P., & Gama, M. J. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8295-4 · Cited by 156 · cited 2×
“Treatment with TUDCA has also been shown to ameliorate ER stress in AD [17] and PD mouse models [10].”
BackgroundPathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis
Singh, I., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00392.x · Cited by 148 · cited 1×
“Using this mouse model and patient samples, studies by our laboratory and others have revealed that VLCFA-induced oxidative stress is an early, key pathogenic factor in X-ALD [29, 31, 35, 57, 73, 74, 85, 94], although the exact mechanisms by which oxidative stress causes neurodegeneration in X-ALD are not entirely cle…”
BackgroundSelf-citationGeneral aspects and neuropathology of X-linked adrenoleukodystrophy
Ferrer, I., Aubourg, P., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00390.x · Cited by 139
Self-citationLópez-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J. M., Fabregat, I., Cacabelos, D., Boada, J., Martínez, J., Ferrer, I., Pamplona, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt186 · Cited by 125 · cited 2×
“The fibroblasts of X-ALD patients are a good surrogate cell model for dissecting disease mechanisms, as they recapitulate the main X-ALD hallmarks: (i) accumulation of VLCFA [101], (ii) higher production of free radicals of mitochondrial origin [58], (iii) loss of energetic homeostasis [34], and (iv) altered proteosta…”
BackgroundSelf-citationSasaki, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d44992 · Cited by 121
Cholesterol biosynthesis and ER stress in peroxisome deficiency
Faust, P. L., & Kovacs, W. J. (2014) · Biochimie · doi:10.1016/j.biochi.2013.10.019 · Cited by 107 · cited 3×
“That may be due to a lack of degradation of GRP78 and GRP94, which may undergo posttranslational modifications such as S-nitrosylation, as shown for PDI and GRP78 [23, 25, 26].”
BackgroundInfluentialFerrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi384 · Cited by 106 · cited 1×
“Morphological abnormalities of the ER compartment have been described in peroxisomal mutants, including Pex5−/− [18] and Abcd2−/− mice [27].”
BackgroundSelf-citationA key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis
Fourcade, S., Ruiz, M., Camps, C., Schlüter, A., Houten, S. M., Mooyer, P. A. W., Pàmpols, T., Dacremont, G., Wanders, R. J. A., Giròs, M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90736.2008 · Cited by 104 · cited 2×
“In addition, VLCFA are elongated from C16:0 in the ER [50, 68], and subsequently imported by ABCD1 and ABCD2 transporters into peroxisomes for degradation via β-oxidation [30, 93].”
BackgroundSelf-citationFaust, P. L., Banka, D., Siriratsivawong, R., Ng, V. G., & Wikander, T. M. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-7059-y · Cited by 82
Keane, M. H., Overmars, H., Wikander, T. M., Ferdinandusse, S., Duran, M., Wanders, R. J. A., & Faust, P. L. (2007) · Hepatology · doi:10.1002/hep.21532 · Cited by 68
Faust, P. L., Su, H.-M., Moser, A., & Moser, H. W. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:2-3:289 · Cited by 60
Cited by
Bile acid signaling in neurodegenerative and neurological disorders
Grant, S. M., & DeMorrow, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175982 · Cited by 185
Peroxisomal ABC Transporters: An Update
Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116093 · Cited by 68
Functional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis
Charles, K. N., Shackelford, J. E., Faust, P. L., Fliesler, S. J., Stangl, H., & Kovacs, W. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.560266 · Cited by 36
“It has been shown that LDL in FCS provides enough cholesterol to suppress SREBP-2 cleavage in wild-type CHO and HEK-293 cells (Hannah et al., 2001; Lee and Ye, 2004).”
BackgroundCoppa, A., Guha, S., Fourcade, S., Parameswaran, J., Ruiz, M., Moser, A. B., Schlüter, A., Murphy, M. P., Lizcano, J. M., Miranda-Vizuete, A., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.177 · Cited by 23
Self-citationImbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy
Launay, N., Lopez-Erauskin, J., Bianchi, P., Guha, S., Parameswaran, J., Coppa, A., Torreni, L., Schlüter, A., Fourcade, S., Paredes-Fuentes, A. J., et al. (2024) · Brain · doi:10.1093/brain/awae038 · Cited by 14
Self-citation
Metadata
- Authors
- Launay, N., Ruiz, M., Grau, L., Ortega, F. J., Ilieva, E. V., Martínez, J. J., Galea, E., Ferrer, I., Knecht, E., Pujol, A., & Fourcade, S.
- Venue
- Acta Neuropathologica
- Published
- 2016-12-21
- Volume
- 133
- Issue
- 2
- Pages
- 283-301
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2565049165
- Cited by
- 62
- References
- 30
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.